Mirion Technologies, Inc.
MIRAPI behind this page
MIR Q1 2026 request
Playground key active
/api/financials?ticker=MIR&year=2026&quarter=1
Pick an endpoint and run the request.Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue | 257.6 | 202 | +27.5% |
Show Product Lines breakouts |
|||
| Cancer care · Medical Segment [Member] | 55.3 | 51 | +8.4% |
| Labs and research · Nuclear & Safety | 28.3 | 26.8 | +5.6% |
| Nuclear power · Nuclear & Safety | 125.8 | 84.1 | +49.6% |
| Other · Medical Segment [Member] | 16.8 | 17.6 | -4.5% |
| Other · Nuclear & Safety | 31.4 | 22.5 | +39.6% |
| Product | 197 | 147.9 | +33.2% |
| Service | 60.6 | 54.1 | +12.0% |
Show Business Segments breakouts |
|||
| Medical Segment [Member] | 72.1 | 68.6 | +5.1% |
| Medical Segment [Member] · Europe | 7.3 | 6.6 | +10.6% |
| Medical Segment [Member] · North America | 64.8 | 62 | +4.5% |
| Nuclear & Safety | 185.5 | 133.4 | +39.1% |
| Nuclear & Safety · Asia Pacific | 4.7 | 5.8 | -19.0% |
| Nuclear & Safety · Europe | 70.6 | 58.9 | +19.9% |
| Nuclear & Safety · North America | 110.2 | 68.7 | +60.4% |
Show Geography breakouts |
|||
| Asia Pacific | 4.7 | 5.8 | -19.0% |
| Europe | 77.9 | 65.5 | +18.9% |
| North America | 175 | 130.7 | +33.9% |
Show Timing Of Transfer Of Good Or Service breakouts |
|||
| Transferred At Point In Time | 167.8 | 129.9 | +29.2% |
| Transferred Over Time | 89.8 | 72.1 | +24.5% |
| Cost of Revenue | 138.5 | 105.9 | +30.8% |
Show Product Lines breakouts |
|||
| Product | 112.9 | 81.7 | +38.2% |
| Service | 25.6 | 24.2 | +5.8% |
| Gross Profit | 119.1 | 96.1 | +23.9% |
| Selling, General & Administrative | 105.8 | 78.7 | +34.4% |
| Research & Development | 9.6 | 8.7 | +10.3% |
| Operating Expenses | 115.4 | 87.4 | +32.0% |
| Operating Income | 3.7 | 8.7 | -57.5% |
| Interest Expense (Q) | — | — | — |
Show Related Party Transactions By Related Party breakouts |
|||
| Nonrelated Party | 8.4 | 12.5 | -32.8% |
| Interest Income | -3.4 | -1.9 | -78.9% |
| Foreign Currency Transaction Gain Loss Before Tax | 3.7 | -2.8 | +232.1% |
| Other Non-Operating Income (Expense) | 0.2 | 0.3 | -33.3% |
| Income Before Taxes | -5.2 | 0.6 | -966.7% |
| Income Tax Expense (Benefit) | -1.8 | 0.2 | -1000.0% |
| Net Income | -3.4 | 0.4 | -950.0% |
Show Equity Components breakouts |
|||
| Retained Earnings | -3.4 | 0.3 | -1233.3% |
| Net Income | -3.4 | 0.3 | -1233.3% |
| EPS (Basic) | -0.01 | 0 | — |
| EPS (Diluted) | -0.01 | 0 | — |
| Wtd Avg Shares (Basic) | 244.66 | 225.66 | +8.4% |
| Wtd Avg Shares (Diluted) | 244.66 | 226.92 | +7.8% |
| Comprehensive Income | -13.4 | 14.2 | -194.4% |
| Interest Expense (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| Convertible Senior Notes Due 2030 (Notes) · Convertible Debt | 0.9 | — | — |
| Convertible Senior Notes Due 2031 (Notes) · Convertible Debt | 0.4 | — | — |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 397.9 | 185.8 | +114.2% |
| Accounts Receivable | 181.5 | 147.8 | +22.8% |
| Contract With Customer Asset Net Current | 98.9 | 71.8 | +37.7% |
Show Major Customers breakouts |
|||
| Uncompleted Contracts | 98.9 | 71.8 | +37.7% |
| Inventory | 157.9 | 143.5 | +10.0% |
| Prepaid Expenses & Other Current Assets | 54.7 | 41 | +33.4% |
| Total Current Assets | 890.9 | 590.2 | +50.9% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 152.6 | 148.2 | +3.0% |
Show Geography breakouts |
|||
| Asia Pacific | 0.1 | 0.1 | 0.0% |
| Europe | 58.6 | 56.3 | +4.1% |
| North America | 93.9 | 91.8 | +2.3% |
| Operating Lease Right-of-Use Assets | 30.8 | 30 | +2.7% |
| Goodwill | 1,860.4 | — | — |
Show Business Segments breakouts |
|||
| Medical Segment [Member] | 634 | — | — |
| Nuclear & Safety | 1,226.4 | — | — |
| Nuclear & Safety · Certrec Corporation | 55.7 | — | — |
| Nuclear & Safety · Paragon | 341.3 | — | — |
| Other Non-Current Assets | 25.2 | 26.8 | -6.0% |
| Total Assets | 3,535.9 | 2,625.6 | +34.7% |
| Intangible Assets | 576 | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Customer Relationships | 272.8 | — | — |
| Developed Technology Rights | 192.1 | — | — |
| Distributor relationships | 28.8 | — | — |
| Remaining performance obligations and other | 13 | — | — |
| Trade Names | 69.3 | — | — |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 576 | 390.7 | +47.4% |
| Current Liabilities | |||
| Accounts Payable | 66.1 | 51.7 | +27.9% |
| Deferred Revenue | 108.1 | 92.2 | +17.2% |
| Current Portion of Long-Term Debt | 1.6 | — | — |
| Operating Lease Liability Current | 7.7 | 6.5 | +18.5% |
| Accrued Liabilities And Other Liabilities | 95.7 | 113.9 | -16.0% |
| Total Current Liabilities | 279.2 | 265 | +5.4% |
| Deferred Revenue (Current) (Q) | — | — | — |
Show Major Customers breakouts |
|||
| Uncompleted Contracts | -34.8 | -27.1 | -28.4% |
| Non-Current Liabilities | |||
| Convertible Debt Noncurrent | 755.6 | — | — |
| Operating Lease Liabilities | 25.5 | 26.4 | -3.4% |
| Deferred Tax Liabilities | 68.1 | 54.1 | +25.9% |
| Other Non-Current Liabilities | 75.5 | 37.5 | +101.3% |
| Total Liabilities | 1,647.4 | 1,068.9 | +54.1% |
| Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| Debt Excluding Convertible Debt | 445.1 | — | — |
| Long-Term Debt | 443.5 | — | — |
| Contract With Customer Liability Noncurrent (Q) | — | — | — |
Show Major Customers breakouts |
|||
| Uncompleted Contracts | -2 | -1.7 | -17.6% |
| Other Liabilities | |||
| Long Term Debt Excluding Current Maturities And Long Term Convertible Debt | 443.5 | — | — |
| Stockholders' Equity | |||
| Treasury Stock Common Value | -78.1 | -23.6 | -230.9% |
| Additional Paid-In Capital | 2,495.1 | 2,147.7 | +16.2% |
| Retained Earnings | -516.1 | -541.2 | +4.6% |
| Accumulated Other Comprehensive Income | -62.6 | -79.1 | +20.9% |
| Total Stockholders' Equity | 1,838.3 | 1,503.8 | +22.2% |
| Minority Interest | 50.2 | 52.9 | -5.1% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 1,888.5 | 1,556.7 | +21.3% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment Including Portion Attributable To Noncontrolling Interest | 2.5 | 2.4 | +4.2% |
| Accumulated Foreign Currency Adjustment Including Portion Attributable To Noncontrolling Interest | -39.9 | -71.6 | +44.3% |
| Accumulated Gain Loss Cash Flow Hedge Including Noncontrolling Interest | 0.2 | 0.1 | +100.0% |
| Accumulated Other Comprehensive Income | -62.6 | -79.1 | +20.9% |
| Accumulated Other Comprehensive Income Loss Derivative Qualifying As Hedge Excluded Component Including Portion Attributable To Noncontrolling Interest | -28.1 | -13.4 | -109.7% |
| Additional Paid In Capital | 2,495.1 | 2,147.7 | +16.2% |
| Aoci Attributable To Noncontrolling Interest | -2.7 | -3.4 | +20.6% |
| Noncontrolling Interest | 50.2 | 52.9 | -5.1% |
| Retained Earnings | -516.1 | -541.2 | +4.6% |
| Treasury Stock Common | -78.1 | -23.6 | -230.9% |
| Total Liabilities & Equity | 3,535.9 | 2,625.6 | +34.7% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Other Depreciation And Amortization | 40.8 | 33.7 | +21.1% |
| Stock-Based Compensation | 4.3 | 3.4 | +26.5% |
| Amortization of Financing Costs | 1.5 | 0.9 | +66.7% |
| Provision For Doubtful Accounts | 0.6 | 0.7 | -14.3% |
| Inventory Write Down | 0.3 | 0.5 | -40.0% |
| Deferred Income Taxes And Tax Credits | -2.6 | -5.7 | +54.4% |
| Gain Loss On Sale Of Property Plant Equipment | 0.1 | 0.1 | 0.0% |
| Foreign Currency Transaction Gain Loss Unrealized | 3.7 | -2.8 | +232.1% |
| Amortization Of Inventory Step Up | 0.8 | — | — |
| Change in Accounts Receivable | -1.8 | 31.1 | -105.8% |
| Increase Decrease In Contract With Customer Asset | -4.7 | -2.1 | -123.8% |
| Change in Inventory | -6.5 | -8.3 | +21.7% |
| Change in Prepaid & Other Assets | -1.9 | -0.5 | -280.0% |
| Change in Accounts Payable | 9.9 | -2.3 | +530.4% |
| Increase Decrease In Accrued Liabilities And Other Liabilities Current | -19.6 | -5.7 | -243.9% |
| Change in Deferred Revenue | -4.2 | -4.4 | +4.5% |
| Increase Decrease In Other Operating Assets | -0.2 | 0.3 | -166.7% |
| Increase Decrease In Other Operating Liabilities | 1.8 | -3.7 | +148.6% |
| Net Cash from Operations | 18.9 | 35.6 | -46.9% |
| Depreciation & Amortization | 40.8 | 33.7 | +21.1% |
Show Business Segments breakouts |
|||
| Medical Segment [Member] · Operating Segments | 16.2 | 16.4 | -1.2% |
| Nuclear & Safety · Operating Segments | 24.3 | 17 | +42.9% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 0.3 | 0.3 | 0.0% |
| Operating Segments | 40.5 | 33.4 | +21.3% |
| Investing Activities | |||
| Capital Expenditures | -9.5 | -8.5 | -11.8% |
| Proceeds From Hedge Investing Activities | 0.3 | 0.9 | -66.7% |
| Net Cash from Investing | -9.2 | -7.6 | -21.1% |
| Financing Activities | |||
| Tax Withholding for Share Compensation | -4.1 | -1.9 | -115.8% |
| Share Repurchases | -16 | -18.6 | +14.0% |
| Payments For Proceeds From Hedge Financing Activities | 0.1 | 0.1 | 0.0% |
| Proceeds From Payments For Other Financing Activities | 0.1 | -0.3 | +133.3% |
| Net Cash from Financing | -19.9 | -21.2 | +6.1% |
| Supplemental | |||
| Interest Paid | 6.7 | 11.8 | -43.2% |
| Unpaid Capital Expenditures | 9.2 | 8.5 | +8.2% |
Show Business Segments breakouts |
|||
| Medical Segment [Member] · Operating Segments | 3.7 | 4.7 | -21.3% |
| Nuclear & Safety · Operating Segments | 4.8 | 3.5 | +37.1% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 0.7 | 0.3 | +133.3% |
| Operating Segments | 8.5 | 8.2 | +3.7% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -4.2 | 3.8 | -210.5% |
| Net Change in Cash | -14.4 | 10.6 | -235.8% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 400.8 | 186.2 | +115.3% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.